Antiarrhythmic Drug Therapy vs Catheter Ablation for Paroxysmal Atrial Fibrillation

被引：1
|
作者：
Srivatsa, Uma N. [1 ]
机构：
[1] Univ Calif Davis, Div Cardiol, Davis, CA 95616 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 303卷 / 18期
关键词：
D O I：
10.1001/jama.2010.539
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1809 / 1809
页数：1
相关论文
共 50 条
  • [31] Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy
    Willems, R
    Wyse, DG
    Gillis, AM
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (12) : 1296 - 1301
  • [32] Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
    Kuniss, Malte
    Pavlovic, Nikola
    Velagic, Vedran
    Hermida, Jean Sylvain
    Healey, Stewart
    Arena, Giuseppe
    Badenco, Nicolas
    Meyer, Christian
    Chen, Jian
    Iacopino, Saverio
    Anselme, Frederic
    Packer, Douglas L.
    Pitschner, Heinz-Friedrich
    de Asmundis, Carlo
    Willems, Stephan
    Di Piazza, Fabio
    Becker, Daniel
    Chierchia, Gian-Battista
    EUROPACE, 2021, 23 (07): : 1033 - 1041
  • [33] Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
    Pokorney, Sean D.
    Daubert, James R.
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1438 - 1441
  • [34] Antikoagulation und Antiarrhythmika nach VorhofflimmerablationAnticoagulation and antiarrhythmic drug therapy after catheter ablation of atrial fibrillation
    H. Volkmann
    C. Bergmann
    M. Walter
    Clinical Research in Cardiology Supplements, 2008, 3 (1) : 118 - 123
  • [35] COST-EFFECTIVENESS OF CATHETER ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF ATRIAL FIBRILLATION IN CANADA
    Mallow, P. J.
    Hsiao, C. W.
    Rizzo, J. A.
    VALUE IN HEALTH, 2013, 16 (03) : A289 - A289
  • [36] COST-EFFECTIVENESS OF CATHETER ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF ATRIAL FIBRILLATION IN THE UK
    Rizzo, J. A.
    Mallow, P.
    Cirrincione, A.
    VALUE IN HEALTH, 2012, 15 (07) : A357 - A357
  • [37] Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
    Packer, Douglas L.
    Mark, Daniel B.
    Robb, Richard A.
    Monahan, Kristi H.
    Bahnson, Tristram D.
    Moretz, Kathleen
    Poole, Jeanne E.
    Mascette, Alice
    Rosenberg, Yves
    Jeffries, Neal
    Al-Khalidi, Hussein R.
    Lee, Kerry L.
    AMERICAN HEART JOURNAL, 2018, 199 : 192 - 199
  • [38] A trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: The APAF study
    DeSilvey, Dennis L.
    AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2007, 16 (03): : 202 - 203
  • [39] Catheter ablation as a class I recommendation therapy for symptomatic, drug-resistant, paroxysmal atrial fibrillation
    Okumura, Ken
    JOURNAL OF ARRHYTHMIA, 2012, 28 (02) : 81 - 81
  • [40] Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study
    Velagic, Vedran
    Pavlovic, NIkola
    Chierchia, Gian-Battista
    Hermida, Jean-Sylvain
    Healey, Stewart
    Arena, Giuseppe
    Badenco, Nicolas
    Meyer, Christian
    Chen, Jian
    Iacopino, Saverio
    Anselme, Frederic
    Kuniss, Malte
    CIRCULATION, 2020, 142
12345